These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 26860867)
1. New Approach for Inhibition of HIV Entry: Modifying CD4 Binding Sites by Thiolated Pyrimidine Derivatives. Kanizsai S; Ongrádi J; Aradi J; Nagy K Pathol Oncol Res; 2016 Jul; 22(3):617-23. PubMed ID: 26860867 [TBL] [Abstract][Full Text] [Related]
2. Differential CD4/CCR5 utilization, gp120 conformation, and neutralization sensitivity between envelopes from a microglia-adapted human immunodeficiency virus type 1 and its parental isolate. Martín J; LaBranche CC; González-Scarano F J Virol; 2001 Apr; 75(8):3568-80. PubMed ID: 11264346 [TBL] [Abstract][Full Text] [Related]
3. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition. Panos G; Watson DC Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642 [TBL] [Abstract][Full Text] [Related]
4. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells. Xiao X; Kinter A; Broder CC; Dimitrov DS Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381 [TBL] [Abstract][Full Text] [Related]
5. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus. Platt EJ; Durnin JP; Kabat D J Virol; 2005 Apr; 79(7):4347-56. PubMed ID: 15767435 [TBL] [Abstract][Full Text] [Related]
6. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs). Agrawal L; Vanhorn-Ali Z; Alkhatib G J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics. Reeves JD; Gallo SA; Ahmad N; Miamidian JL; Harvey PE; Sharron M; Pohlmann S; Sfakianos JN; Derdeyn CA; Blumenthal R; Hunter E; Doms RW Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16249-54. PubMed ID: 12444251 [TBL] [Abstract][Full Text] [Related]
8. Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1. Esser U; Speck RF; Deen KC; Atchison RE; Sweet R; Goldsmith MA AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1845-54. PubMed ID: 11118070 [TBL] [Abstract][Full Text] [Related]
9. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage. Verrier F; Borman AM; Brand D; Girard M AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469 [TBL] [Abstract][Full Text] [Related]
10. Replacement of the V3 region of gp120 with SDF-1 preserves the infectivity of T-cell line-tropic human immunodeficiency virus type 1. Yonezawa A; Hori T; Takaori-Kondo A; Morita R; Uchiyama T J Virol; 2001 May; 75(9):4258-67. PubMed ID: 11287575 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. Popik W; Alce TM; Au WC J Virol; 2002 May; 76(10):4709-22. PubMed ID: 11967288 [TBL] [Abstract][Full Text] [Related]
12. Nef stimulates human immunodeficiency virus type 1 replication in primary T cells by enhancing virion-associated gp120 levels: coreceptor-dependent requirement for Nef in viral replication. Lundquist CA; Zhou J; Aiken C J Virol; 2004 Jun; 78(12):6287-96. PubMed ID: 15163722 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry. Pugach P; Marozsan AJ; Ketas TJ; Landes EL; Moore JP; Kuhmann SE Virology; 2007 Apr; 361(1):212-28. PubMed ID: 17166540 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein. Bosch B; Blanco J; Pauls E; Clotet-Codina I; Armand-Ugón M; Grigorov B; Muriaux D; Clotet B; Darlix JL; Esté JA Antimicrob Agents Chemother; 2005 Oct; 49(10):4296-304. PubMed ID: 16189111 [TBL] [Abstract][Full Text] [Related]
15. An immunoglobulin fusion protein based on the gp120-CD4 receptor complex potently inhibits human immunodeficiency virus type 1 in vitro. Vu JR; Fouts T; Bobb K; Burns J; McDermott B; Israel DI; Godfrey K; DeVico A AIDS Res Hum Retroviruses; 2006 Jun; 22(6):477-90. PubMed ID: 16796521 [TBL] [Abstract][Full Text] [Related]
16. Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion. Finnegan CM; Rawat SS; Cho EH; Guiffre DL; Lockett S; Merrill AH; Blumenthal R J Virol; 2007 May; 81(10):5294-304. PubMed ID: 17344303 [TBL] [Abstract][Full Text] [Related]
17. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D). Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415 [TBL] [Abstract][Full Text] [Related]
18. Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc. Borm K; Jakobsen MR; Cashin K; Flynn JK; Ellenberg P; Ostergaard L; Lee B; Churchill MJ; Roche M; Gorry PR Retrovirology; 2016 Nov; 13(1):74. PubMed ID: 27809912 [TBL] [Abstract][Full Text] [Related]
19. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage. Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360 [TBL] [Abstract][Full Text] [Related]
20. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]